Showing posts with label BREAST FEEDING REDUCES DIABETES. Show all posts
Showing posts with label BREAST FEEDING REDUCES DIABETES. Show all posts

Sunday, March 15, 2009

BREAST FEEDING REDUCES RISK OF DIABETES MELLITEUS

Breastfeeding and risk reduction
in type-2 diabetes
Breastfeeding may provide a degree of
long-term protection against the deve-
lopment of type-2 diabetes, which could
be of public health importance. Longer
duration of breastfeeding was associated
with reduced incidence of type-2 diabe-
tes mellitus in two large US cohorts of young and middle-aged women
16
, the
Nurses’ Health Studies I and II. In sup-
port of this, the Shanghai Women’s
Health Study also demonstrated that
longer duration of breastfeeding was as-
sociated with a reduced risk of type-2
diabetes mellitus, independently of known
risk factors for type-2 diabetes mellitus
17
.
Previous studies have documented a
lower prevalence of breastfeeding among
African–American infants than among
infants of other races/ethnicities
18
. There-
fore, it is advised that targeting popu-
lation subgroups at relatively high risk
both for type-2 diabetes and low preva-
lence of breastfeeding, may offer an im-
portant opportunity for primary prevention
of type-2 diabetes through promotion of
breastfeeding.
In our fast-paced and pre-packaged
world, it is easy to stay away from natu-
ral foods. However, when life is just
starting out, nothing is better for baby
than the most natural food of all –
breastfeeding. Breastfeeding has been a
part of our culture since ancient times.
But with modernization, breastfeeding
practices have gradually declined. This
has resulted in activities for increasing
awareness and promotion of breastfeeding.
According to the Indian Academy of Pe-
diatrics Policy on Infant Feeding, ‘an
ideal infant feeding comprises exclusive
breastfeeding for 6 months followed by
sequential addition of semi-solid and
solid foods to complement (not replace)
breast milk till the child is gradually able
to eat normal family food (around one
year)’. The latter period is also referred
to as weaning. The term ‘weaning’ does
not denote termination of breastfeeding.

ADIPO NECTIN IN HUMAN MILK

Adiponectin in human milk!
High concentrations of circulating adipo-
nectin have positive health effects through the reduction of proinflammatory cyto-
kines, improvement of insulin sensitivity,
and increase in fatty-acid metabolism.
Recently, Martin et al.
12
reported that adi-
ponectin is present in human milk and is
associated with maternal factors. The
concentration of adiponectin in milk is
much lower than in the serum, but ap-
pears to have biological significance for
breastfeeding infants. Previous studies
have shown that milk components are not
often degraded in the stomach, in part
because the composition of human milk
forms a protective environment for pro-
teins and in part because of the reduced
acidity of the infant stomach and limited
gastric proteolysis. Second, physiologi-
cal actions of adiponectin could be im-
portant in developing infants. Because
adiponectin has been shown to increase
insulin sensitivity, it may also augment
the action of insulin in the gut of infants.
Adiponectin may also have direct effect
on the gut of infants, because previous
studies have documented that adiponectin
receptor 1 is expressed in foetal small in-
testine
13
. Bronsky et al.
14
have reported
that concentrations of adiponectin, adipo-
cyte fatty acid-binding protein, and epi-
dermal fatty acid-binding protein in human
breast milk are related to nutritional
variables of mothers and newborns, and
thus may play a role in the protective ef-
fects of breastfeeding. Since circulatory
adiponectin levels were demonstrated to
be lower in Asian Indians with metabolic
syndrome
15
, it would be interesting to
know the milk adiponectin levels and
their physiological role in Indians. In this
context, long-term follow-up studies are
needed to assess the development of
symptoms of metabolic diseases in rela-
tionship to adiponectin breast-milk con-
centrations

BIOLOGICAL EFFECTS OF BREAST FEEDING

What would be the biological
effects of breastfeeding?
It is suggested that potential causal mecha-
nisms for an association of breastfeeding
with a reduction in childhood obesity in-
clude satiety signalling in response to nu-
tritional composition of breast milk
5
and
overfeeding among bottle-fed infants,
who exhibit significantly higher plasma
insulin levels and a prolonged insulin re-
sponse
6
compared with breastfed infants.
There might be many mechanisms other
than weight status that could account for
a protective association between breast-
feeding and type-2 diabetes. Studies
conducted in infants in contrast to those
conducted in children and adults, showed
consistent associations between breast-
feeding and lower glucose and insulin
concentrations. These differences could
reflect lower energy intake in breastfeed-
ing infants than in formula-fed infants
7
,
differences between breast-milk compo-
sition and formulas (particularly the amino
acid and protein contents), or hormonal
differences that result in lower levels of
fat deposition in breastfed infants
4,8
. An-
other possible mechanism is that breast-
feeding may improve insulin sensitivity
and glucose intolerance. In a study of
both breastfeeding and non-breastfeeding
nondiabetic women, insulin levels and
insulin/glucose ratios were lower, while
carbohydrate use and total energy expen-
diture were higher in the breastfeeding
group
9
. Various environmental toxins,
particularly endocrine-disrupting chemi-
cals, have recently been postulated as
contributors to obesity and related meta-
bolic disorders. These include bisphenol-
A, which has been widely incorporated
into plastic products, including infant
feeding bottles
10
and which has been as-
sociated with both reduced pancreatic b-
cell function and insulin resistanc

BREAST FEEDING

There is an intense interest in the effects
of breastfeeding on the health of an off-
spring and in understanding the mecha-
nisms behind these effects. It is widely
known that breastfeeding is the most nu-
tritious way to feed an infant, but it is
less known that the benefits that a child
and mother receive from breastfeeding
continue throughout life, even after
breastfeeding has stopped. The most im-
portant short-term immunological benefit
of breastfeeding is protection against in-
fectious diseases. There is also some evi-
dence of lower prevalence of inflammatory
bowel diseases, childhood cancers, and
type-I diabetes in breast-fed infants, sug-
gesting that breastfeeding influences de-
velopment of the own immune system of
an infant
1
. One of the most consistent
findings of breastfeeding is also a posi-
tive effect on later intelligence tests, with
a few test points advantage for breast-fed
infants

Is breastfeeding a best lifestyle
approach to prevent and reduce
non-communicable diseases?
In the last few years, several systematic
reviews and meta-analyses have exam-
ined the effect of breastfeeding on non-
communicable diseases
2
. There seems to
be a protective effect against later over-
weight and obesity. Blood pressure and
blood cholesterol seem to be slightly lower
in individuals who were breastfed as in-
fants. Identification of lifestyle approaches,
including breastfeeding practices are now
considered an ideal way to decrease the
dramatic increases in childhood obesity
and the emergence of type-2 diabetes in
youth, and to primary prevention of both
conditions. Among adults, breastfeeding
in infancy has been associated with re-
duced risk of type-2 diabetes
3
, but little
is known regarding the potential benefi-
cial effect of breastfeeding on the deve-
lopment of type-2 diabetes in adolescence.
Mayer-Davis et al.
4
have recently re-
ported a protective association of breast-
feeding against the development of type-
2 diabetes in youth in a dose-response
fashion, independent of other potentially
confounding variables. Attenuation of
the odds ratios when body mass index
score was added to the models was consistent with a causal pathway in which
breastfeeding may lower the risk for
childhood overweight, which may in turn
reduce risk for type-2 diabetes